This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)
C3_GALLBLADDER_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
229 |
4. Check minimum number of eventsNone |
229 |
5. Include endpointsNone |
229 |
6. Filter based on genotype QC (FinnGen only) |
229 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 229 | 141 | 88 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | 69.93 | 69.32 | 70.91 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 138
- Matched controls
- 1379
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
+∞
162.4
122
*
8140/3-C23.9
ICD-O-3
Adenocarcinoma, NOS, of gallbladder
+∞
107.9
89
*
130
Kela drug reimbursment
Malignant tumour
+∞
78.9
68
*
H02AB02
ATC
dexamethasone; systemic
308.9
44.8
43
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
41.8
38
*
A03FA01
ATC
metoclopramide; systemic, rectal
17.0
40.6
72
83
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
38.3
35
*
L01BC06
ATC
capecitabine; oral
+∞
36.0
33
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
58.9
27.9
32
7
JKA20
NOMESCO Finland
Cholecystectomy
49.3
26.2
31
8
Z51.5
ICD-10 Finland
Palliative care
28.8
26.0
35
16
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
24.7
23
*
8000/3-C23.9
ICD-O-3
Neoplasm, malignant of gallbladder
+∞
24.7
23
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
106.0
24.6
26
*
N02AA05
ATC
oxycodone; systemic
8.8
23.8
58
105
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
22.5
21
*
UJK02
NOMESCO Finland
ERCP
26.6
20.5
28
13
JN4CD
NOMESCO Finland
Very extensive body CT
54.7
19.9
23
5
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
45.5
19.2
23
6
K83.0
ICD-10 Finland
Cholangitis
40.8
17.2
21
6
JJB30
NOMESCO Finland
Excision of two segments of liver
+∞
17.0
16
*
JN4BD
NOMESCO Finland
Extensive body CT
10.9
16.4
32
37
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
7.3
15.9
41
75
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
15.9
15
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.4
15.7
55
150
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
64.1
15.2
17
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
8.9
14.6
32
45
K83.1
ICD-10 Finland
Obstruction of bile duct
48.1
14.5
17
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
13.6
14.0
24
21
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
83.3
13.9
15
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
13.8
13
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
22.7
12.8
18
9
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
+∞
12.7
12
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.9
12.6
24
26
A04AA01
ATC
ondansetron; systemic, rectal
20.5
12.4
18
10
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
5.6
12.0
37
84
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.9
11.8
30
53
WX408
NOMESCO Finland
General anesthesy, balanced
4.3
11.6
50
161
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
11.6
11
*
JN4AD
NOMESCO Finland
Body CT examination
12.0
10.7
19
18
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
10.5
10
*
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
+∞
10.5
10
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
10.5
10
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
10.4
10.4
20
22
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
9.0
10.1
21
27
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
22.0
10.0
14
7
WZC30
NOMESCO Finland
Teaching
6.2
9.5
26
50
JAH00
NOMESCO Finland
Laparotomy
20.3
9.1
13
7
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
26.1
9.1
12
5
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.4
8
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
8.4
8
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
8.4
8
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
8.4
8
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
8.4
8
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.3
7.9
30
84
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
47.7
7.8
9
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
19.7
7.7
11
6
D77
ICPC
Malignant digestive neopl other/NOS
+∞
7.4
7
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
7.4
7
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
7.4
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.4
7
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
21.4
7.2
10
5
XX3DW
NOMESCO Finland
Time consuming IT work
7.4
7.1
16
24
WX402
NOMESCO Finland
General anaesthesia
4.3
6.8
25
67
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
23.9
6.8
9
*
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
7.5
6.7
15
22
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
13.1
6.7
11
9
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
8.8
6.5
13
16
K82.9
ICD-10 Finland
Disease of gallbladder, unspecified
73.1
6.5
7
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
6.3
6
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
6.3
6
*
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
13.3
6.2
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
123
101
25.15
135.80
7.0
1.4
ug/l
14.9
5.4
0.94
117
84
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
75
41
26.71
98.54
7.0
1.7
u/ml
1498.2
171.3
1.20
70
33
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
57
17
44.31
92.03
3.3
1.5
u/ml
641.0
220.4
0.27
57
17
(4035726)
46
47
12.00
41.49
1.6
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
66
120
7.32
37.22
3.7
1.8
g/l
0.2
0.2
0.56
66
104
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
77
166
6.48
36.63
8.0
1.8
umol/l
22.9
6.5
1.78
72
140
(3002256) Pathology report gross observation
59
109
6.94
32.49
1.6
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
52
128
4.96
20.49
6.5
5.8
mmol/l
6.1
10.6
5.56
52
120
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
149
842
3.20
15.93
24.4
3.4
umol/l
19.0
11.7
1.38
149
784
(3023368) Bacteria identified in Blood by Culture
97
452
2.99
14.28
6.0
3.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
128
713
2.80
13.20
12.0
9.9
inr
1.2
1.4
1.55
38
202
(3044640) Blood type and Crossmatch panel - Blood
95
454
2.87
13.15
2.9
2.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
17
7
26.07
12.66
1.5
1.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
82
371
2.89
12.46
9.6
3.2
%
87.5
88.2
0.08
82
360
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
120
697
2.52
10.67
5.4
3.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
74
347
2.67
10.22
2.6
1.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
28
79
3.90
9.00
6.5
6.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
35
117
3.35
8.76
1.4
1.4
%
1.4
1.6
0.90
30
100
(40768804) Tissue Pathology biopsy report
89
497
2.29
8.12
3.2
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
32
107
3.31
7.99
1.5
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
132
1721
0.45
7.80
5.1
5.5
mmol/l
2.7
2.7
0.05
117
1556
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
127
1672
0.46
7.49
4.9
4.8
mmol/l
4.7
4.6
0.48
115
1523
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
126
1659
0.47
7.31
4.7
4.8
mmol/l
1.5
1.5
0.19
114
1503
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
32
114
3.10
7.19
1.5
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
131
1697
0.47
7.15
4.7
4.9
mmol/l
6.3
6.1
0.55
124
1526
(3003694) ABO and Rh group [Type] in Blood
67
355
2.25
6.75
1.3
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
29
5.08
6.54
1.3
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
124
1618
0.49
6.43
6.2
6.4
mmol/mol
42.2
40.7
0.68
111
1492
(3042936) Bacteria identified in Isolate by Culture
47
218
2.45
6.38
2.3
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
131
910
2.03
6.35
21.4
5.5
e9/l
4.1
4.3
0.58
124
781
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
123
1599
0.50
6.07
4.5
4.3
mmol/l
1.3
1.3
0.69
111
1433
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
45
212
2.40
5.89
2.3
2.4
%
23.8
22.0
0.33
40
186
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
27
110
2.65
4.75
2.0
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
21
4.93
4.57
1.4
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
158
1851
0.53
4.50
49.2
19.5
g/l
123.1
134.0
14.81
158
1815
(3035941) MCH [Entitic mass]
158
1851
0.53
4.50
48.8
19.3
pg
30.2
30.3
0.32
158
1817
(3024731) MCV [Entitic volume]
158
1850
0.53
4.47
48.9
19.3
fl
91.6
91.5
0.06
158
1816
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
118
858
1.77
4.37
7.3
4.9
mmol/l
1.2
1.2
4.26
101
740
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
10
8.24
4.09
2.4
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
7
10.26
4.03
1.0
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
39
202
2.12
4.03
5.7
5.6
mmol/l
1.1
1.6
0.48
31
162
(3022948) Iron [Moles/volume] in Serum or Plasma
46
254
2.01
4.02
2.5
2.2
umol/l
13.1
12.6
0.18
46
226
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
129
1576
0.58
3.80
4.6
5.0
mu/l
2.0
2.0
0.22
119
1418
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
26
3.98
3.56
1.5
2.7
%
60.3
61.2
—
10
26
(1761868) Lipid panel - Serum or Plasma
28
518
0.48
3.42
2.8
3.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
77
528
1.69
3.31
3.6
2.9
ph
7.4
7.4
0.41
18
75
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
7
8.76
3.28
4.7
1.4
nmol/l
2.8
5.8
—
6
7
(40758558) Short blood count panel - Blood
60
387
1.75
3.21
12.3
4.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
17
67
2.66
3.21
1.8
1.6
ug/l
0.8
2.0
0.95
17
56
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
26
481
0.48
3.15
1.8
1.6
mmol/l
1.3
1.3
0.12
20
402
(3020564) Creatinine [Moles/volume] in Serum or Plasma
156
1790
0.60
3.13
42.3
15.7
umol/l
73.6
78.2
1.64
156
1790
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
25
120
2.22
3.12
5.2
2.8
mmol/l
1.2
1.2
0.09
25
97
(42870588) Differential panel, method unspecified - Blood
73
505
1.65
3.00
3.9
5.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
22
103
2.26
2.91
2.7
3.4
%
1.0
0.3
0.80
11
19
(3017181) Myelocytes/100 leukocytes in Blood
24
117
2.17
2.89
2.8
3.3
%
1.5
0.7
0.51
14
28
(3003338) MCHC [Mass/volume]
115
1401
0.64
2.80
42.3
17.8
g/l
330.8
331.0
0.11
115
1392
(40761511) CBC panel - Blood by Automated count
152
1742
0.62
2.80
34.2
12.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
50
2.70
2.58
1.6
2.3
u/ml
0.4
0.4
—
7
28
(40761536) Microorganisms panel - Urine sediment
24
123
2.06
2.56
4.8
3.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
14
302
0.43
2.54
1.1
1.3
iu/ml
47.7
41.4
—
9
100
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
158
1784
0.63
2.53
29.8
9.1
u/l
33.1
24.1
5.31
158
1707
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
26
3.56
2.51
1.6
2.0
e9/l
3.1
4.8
—
9
26
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
43
272
1.72
2.43
1.6
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
18
85
2.21
2.36
5.5
5.3
mmol/l
25.0
25.4
0.31
18
85
(3019060) Gas panel - Arterial blood
23
121
2.00
2.30
4.8
4.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
109
1306
0.68
2.12
3.6
4.1
pmol/l
15.3
15.0
0.35
97
1173
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
161
0.36
2.12
2.0
1.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
55
0.00
2.10
0.0
1.2
—
4.0
—
0
9
(3019832) Treponema pallidum Ab [Presence] in Serum
0
55
0.00
2.10
0.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
10
5.08
2.08
1.6
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
125
1452
0.69
1.98
32.0
14.7
%
35.8
39.5
3.19
83
941
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
19
99
2.00
1.97
6.6
6.8
%
0.7
0.7
0.02
19
99
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
19
99
2.00
1.97
6.2
6.8
%
1.4
1.4
0.08
19
99
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
0
52
0.00
1.90
0.0
1.2
—
3.7
—
0
9
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
15
283
0.50
1.89
1.1
1.3
u/ml
1.3
14.0
—
5
98
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
46
2.46
1.88
1.3
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
43
606
0.64
1.85
4.4
3.8
mg/mmol
13.5
6.4
0.38
24
367
(3009508) Creatinine [Moles/volume] in Urine
41
579
0.64
1.78
3.7
3.0
mmol/l
6.4
7.0
0.61
35
479
(3021440) Promyelocytes/100 leukocytes in Blood
20
111
1.88
1.75
3.0
3.4
%
0.1
0.0
0.17
13
25
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
78
612
1.42
1.66
2.8
3.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
27
171
1.66
1.54
5.1
3.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
45
0.00
1.51
0.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
42
572
0.67
1.50
3.6
3.1
mg/l
1847.5
278.4
0.41
24
352
(3014111) Lactate [Moles/volume] in Serum or Plasma
25
157
1.66
1.48
6.0
4.7
mmol/l
2.0
1.4
0.35
25
151
(3002582) Erythrocytes [#/volume] in Urine
67
522
1.40
1.47
2.3
3.0
e6/l
61.2
169.0
0.38
56
389
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
16
3.17
1.44
1.0
1.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
22
2.77
1.44
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
40
2.30
1.42
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
40
2.30
1.42
1.2
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
39
276
1.50
1.41
12.6
23.3
inr
1.2
1.3
—
8
42
(1616796) Gas panel - Central venous blood
7
29
2.46
1.40
2.4
2.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
59
455
1.40
1.37
2.3
2.8
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
17
2.98
1.36
1.2
1.4
%
90.4
89.3
—
5
17
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
142
1573
0.74
1.34
32.5
12.3
ml/min/173m2
78.7
73.6
2.23
132
1248
(3023419) Bacteria identified in Sputum by Culture
6
24
2.54
1.31
1.8
3.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
61
477
1.38
1.30
2.3
2.9
e6/l
0.6
0.6
0.11
48
343
(3013707) Erythrocyte sedimentation rate by Westergren method
112
1280
0.76
1.30
4.2
4.3
mm/h
19.8
13.4
2.71
106
1161
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
18
2.82
1.29
1.2
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
29
197
1.54
1.27
1.4
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
46
344
1.42
1.27
4.7
3.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
25
2.44
1.25
1.8
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
29
198
1.53
1.24
1.4
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
37
2.20
1.22
1.1
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
15
87
1.77
1.18
7.1
6.5
mmol/l
24.0
24.9
0.99
15
80
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
35
0.00
1.16
0.0
2.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
20
2.53
1.15
1.2
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
21
2.41
1.09
1.4
1.1
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
7
32
2.22
1.09
2.4
2.3
kpa
4.9
5.0
—
7
32
(3027315) Oxygen [Partial pressure] in Blood
7
32
2.22
1.09
2.4
2.3
kpa
8.3
7.9
—
7
32
(3012501) Base excess in Blood by calculation
7
32
2.22
1.09
2.4
2.3
mmol/l
1.8
2.7
—
7
18
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
32
2.22
1.09
1.1
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
36
265
1.43
1.09
1.5
1.7
s
30.8
29.2
0.84
36
254
(3029937) Albumin [Presence] in Urine by Test strip
57
456
1.33
1.05
4.7
4.1
estimate
0.0
0.0
0.00
25
133
(3025159) Blasts/100 leukocytes in Blood
17
107
1.64
1.03
3.1
3.4
%
0.2
0.0
0.47
11
22
(3000991) Gas panel - Venous blood
21
140
1.55
1.01
6.9
5.8
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
5
23
2.20
0.98
1.2
1.3
pmol/l
92.8
75.8
—
5
23
(4010399)
7
126
0.54
0.91
1.3
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
72
606
1.27
0.91
2.4
3.5
e6/l
99.4
123.1
0.23
57
419
(40760888) Immunoglobulin light chains.free panel - Serum
6
29
2.10
0.90
1.3
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
36
458
0.75
0.85
4.5
3.7
ug/l
2.4
2.1
0.25
29
405
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
15
97
1.58
0.83
3.0
3.8
kpa
5.0
5.2
0.55
15
88
(3001604) Monocytes [#/volume] in Blood
93
814
1.24
0.83
5.6
4.6
e9/l
0.6
0.6
0.08
83
689
(3023420) DNA double strand Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
48
1.69
0.79
1.9
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
69
801
0.80
0.79
2.1
2.0
pmol/l
96.2
93.8
0.18
44
370
(46235355) HIV 1 and 2 tests - Meaningful Use set
19
132
1.48
0.79
1.2
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
93
819
1.23
0.78
5.6
4.6
e9/l
0.0
0.0
0.85
82
693
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
14
91
1.57
0.77
3.1
3.7
mmol/l
2.0
2.3
—
8
66
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
86
753
1.23
0.76
4.0
4.0
ng/l
43.9
80.0
0.33
71
550
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
18
251
0.69
0.74
2.2
2.5
ug/l
1.0
0.8
0.65
11
171
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
11
68
1.65
0.73
1.5
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
93
825
1.21
0.72
5.8
4.7
e9/l
1.6
1.8
2.68
83
717
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
71
813
0.82
0.70
2.0
2.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
95
849
1.20
0.67
5.7
4.6
e9/l
0.2
0.2
1.40
85
727
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
28
1.80
0.66
1.2
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
62
1.64
0.66
1.3
1.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
101
0.58
0.63
3.8
2.1
%
1.0
1.2
—
6
101
(3020891) Body temperature
11
71
1.58
0.63
3.5
4.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
19
139
1.40
0.63
2.2
1.4
g/l
67.0
66.8
0.03
19
120
(3021901) Oxygen saturation in Capillary blood
5
30
1.68
0.62
1.8
2.2
—
—
—
0
0
(3044889) 12 lead EKG panel
114
1237
0.84
0.61
4.5
4.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
21
158
1.36
0.59
4.2
3.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
22
0.00
0.59
0.0
1.1
—
7.5
—
0
16
(3025941) Bacteria identified in Stool by Culture
13
89
1.49
0.59
1.3
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
70
615
1.20
0.58
2.9
3.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
53
453
1.22
0.58
3.6
3.7
—
—
—
0
0
(3036489) Thrombin time
8
54
1.50
0.58
1.5
2.4
s
20.8
21.3
—
8
49
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
123
0.64
0.56
1.0
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
17
125
1.39
0.55
1.8
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
6
38
1.59
0.54
3.0
2.0
mg/l
1.3
1.6
—
6
33
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
74
658
1.18
0.54
4.3
4.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
81
728
1.17
0.52
1.9
2.2
nmol/l
79.9
80.0
0.01
76
632
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
29
353
0.80
0.51
1.2
1.3
u/ml
0.6
1.9
—
7
95
(3015736) pH of Urine
60
678
0.84
0.50
4.1
3.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
110
1.39
0.50
3.0
2.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
46
1.54
0.48
3.3
3.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
17
220
0.75
0.47
15.5
7.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
21
167
1.28
0.43
2.0
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
33
1.53
0.41
1.0
1.5
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
15
0.00
0.41
0.0
1.1
—
35.4
—
0
15
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
35
407
0.83
0.40
4.3
3.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
19
0.00
0.39
0.0
1.6
—
322.0
—
0
5
(3013512) EKG study
59
531
1.15
0.37
3.6
4.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
19
153
1.26
0.37
3.5
2.9
—
—
—
0
0
(4094501)
6
42
1.44
0.36
1.3
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
7
98
0.71
0.31
1.0
1.2
iu/ml
—
104.2
—
0
33
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
69
637
1.12
0.30
2.2
2.8
ng/l
840.2
1634.3
2.44
63
531
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
65
1.24
0.27
1.1
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18
212
0.84
0.25
1.7
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
133
1.22
0.25
5.2
1.9
ml/min/173m2
68.1
58.0
—
10
50
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
22
190
1.17
0.24
1.1
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
42
1.19
0.21
2.2
2.3
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.0
—
770.4
—
0
11
(3011288) Drugs identified in Urine by Screen method
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4027681)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.0
—
28.6
—
0
5
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
10
0.00
0.21
0.0
1.2
—
8.2
—
0
10
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
1.1
—
0
7
(3025130) Human papilloma virus identified in Specimen
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.9
—
26.8
—
0
5
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
46
425
1.10
0.20
1.7
1.7
pmol/l
493.5
462.3
0.31
40
342
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
30
270
1.13
0.20
2.0
2.8
e6/l
5.9
3.5
0.32
15
140
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
33
363
0.89
0.20
3.3
3.4
%
23.6
24.6
0.16
14
177
(3000492) Spirometry study
11
132
0.82
0.18
1.5
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
59
1.19
0.18
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
59
1.19
0.18
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
60
1.17
0.18
1.3
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
61
1.15
0.17
1.3
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
70
1.15
0.16
1.4
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
71
1.13
0.16
1.8
2.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
13
149
0.86
0.14
3.8
2.5
kpa
4.2
4.3
0.02
13
143
(3037467) Urinalysis macro (dipstick) panel - Urine
121
1177
1.06
0.14
5.0
4.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
27
248
1.10
0.13
1.3
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
35
375
0.92
0.13
1.4
1.7
mg/l
2.2
1.2
0.69
26
292
(3052851) Hemolysis interference index of Serum or Plasma
5
45
1.11
0.10
5.4
3.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
45
1.11
0.10
1.4
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
5
46
1.09
0.09
3.0
2.8
mmol/l
7.0
7.6
—
5
46
(3008037) Lactate [Moles/volume] in Venous blood
5
47
1.07
0.09
3.0
2.8
mmol/l
1.3
1.5
—
5
47
(3007853) Bacteria identified in Skin by Aerobe culture
21
194
1.09
0.09
2.1
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
126
1.12
0.09
3.3
2.8
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
5
61
0.82
0.08
1.2
1.1
g/l
34.7
38.1
—
5
50
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
63
0.79
0.08
1.2
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
6
73
0.82
0.07
1.3
2.0
u/l
35.3
41.0
—
6
62
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
75
1.07
0.07
1.1
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
13
121
1.08
0.04
1.1
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
40
411
0.97
0.03
4.5
4.2
kg/l
1.0
1.0
0.38
13
70
(3009261) Glucose [Presence] in Urine by Test strip
87
858
1.02
0.03
4.2
3.9
estimate
0.0
0.0
0.00
26
137
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
28
289
0.96
0.02
2.0
2.6
e6/l
2.0
1.1
0.39
13
156
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
113
1.07
0.02
1.8
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
20
193
1.04
0.01
1.4
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
85
842
1.02
0.01
4.1
3.9
estimate
0.0
0.0
0.00
27
138
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
109
1.01
0.00
1.5
1.7
—
—
—
0
0
(3012544) pH of Venous blood
19
189
1.01
0.00
2.9
3.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
29
291
1.00
0.00
1.6
1.2
g/l
2.0
2.5
1.71
21
154
(3021601) Nitrite [Presence] in Urine by Test strip
85
849
1.00
0.00
4.9
5.2
estimate
0.0
0.0
0.00
26
135
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
40
395
1.02
0.00
4.3
4.1
ng/l
229.4
242.2
0.03
30
343
(3019309) Folate [Moles/volume] in Red Blood Cells
40
395
1.02
0.00
1.7
1.8
nmol/l
1216.4
1201.6
0.03
32
300
(3000330) Specific gravity of Urine by Test strip
10
104
0.96
0.00
2.6
4.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
72
717
1.01
0.00
21.5
7.7
e9/l
0.0
0.0
0.55
63
585
(44806420)
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
5
53
0.94
0.00
1.2
1.1
g/l
0.0
0.0
—
5
48
(3015183) Erythrocyte sedimentation rate
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
1.7
—
0
6
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
5
55
0.91
0.00
1.2
1.2
g/l
0.0
0.0
—
5
50
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(44813793)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
1612.8
—
0
6
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
8
0.00
0.00
0.0
14.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
10.2
—
0
7
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
8.0
—
0
7
(3035880) pH of Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
7
69
1.01
0.00
4.7
4.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.2
—
109.2
—
0
6
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
7
76
0.92
0.00
1.9
2.2
nmol/l
13.4
16.2
—
7
70
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
5
59
0.84
0.00
1.2
1.2
g/l
0.0
0.1
—
5
51
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_GALLBLADDER_EXALLC – Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).